ADHD and New Medications

R150.00

02 March 2022
Speaker: Professor Andre Venter
HPCSA awards 1 CEUs

Many children who have a diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) are treated on medication. This talk will focus on the aspects of ADHD which in itself impose barriers on learning, and the co-morbid learning disorders often found in these children.

Out of stock

SKU: ADHD-NM Category:

Professor André Venter currently is the Academic Head of the Department of Paediatrics and Child Health at the University of the Free State. His special area of interest is child development and he obtained his Doctorate in 1991 in this field at the University of Alberta, Canada. He is particularly interested in Cerebral Palsy, Attention Deficit and Hyperactivity, Autism and learning problems. He is the founder and immediate past National Chairman of PANDA-SA (Paediatric Neurology and Development Association of Southern Africa). He is a member of the Advisory Board for Sensory Integration, was an executive member of the International Child Neurology Association and first president of the African Child Neurology Association since 2010.

Many children who have a diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) are treated on medication. This talk will focus on the aspects of ADHD which in itself impose barriers on learning, and the co-morbid learning disorders often found in these children.  Often there are unrealistic expectations regarding to which extent medication may address some of these barriers.  The role of medication for ADHD and its possible positive effects on learning barriers will be discussed.   On the other hand, unrealistic expectations of this intervention will also be highlighted.

HPCSA awards 1 CEU

16 February 2022 @ 19h30 – 20h30 SAST

Reviews

There are no reviews yet.

Be the first to review “ADHD and New Medications”
Scroll to Top